Pharmaceutical Packaging Market worth $251.6 billion by 2034 - Exclusive Report by The Research Insights
CHICAGO, May 13, 2025 /PRNewswire/ -- The global Pharmaceutical Packaging Market is projected to be valued at US$ 139.2 billion in 2024 and reach USD 251.6 billion by 2034, growing at a CAGR of 6.1% according to a new report by The Research Insights. The market for pharmaceutical packaging is driven by the rising demand for adoption of branded and generic medicines in emerging economies across the globe which have propelled the demand for its packaging.
Market Overview and Growth Trajectory:
Pharmaceutical Packaging Market Growth: According to an exhaustive report by The Research Insights, the Pharmaceutical Packaging Market is experiencing significant growth, driven by the increasing focus on environmental sustainability is transforming various industries including the pharmaceutical packaging market. Because consumers along with governmental bodies and healthcare providers prioritize sustainable practices more than ever before they now seek packaging solutions that serve environmental health in addition to their functional purpose. Biodegradable films along with recyclable blister packs and paper-based secondary packaging solutions together with refillable container systems are becoming more popular. The pharmaceutical packaging market valued at US$ 139.2 billion in 2024, is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.1% during 2025–2034.
For More Information and To Stay Updated on The Latest Developments in The Pharmaceutical Packaging Market, Download The Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Escalating the Role of Packaging in Modern Healthcare: The smart healthcare industry's constant evolution has positioned patient safety and drug integrity at the forefront while recognizing packaging as an essential element in fulfilling this mission. The pharmaceutical packaging market adapts to urgent demands for protection against medication contamination, tampering risks and human mistakes. International health authorities and governments have enforced strict regulatory measures aimed at protecting pharmaceutical supply chains. From the U.S. FDA's Drug Supply Chain Security Act to Europe's Falsified Medicines Directive, the message is clear: Product packaging needs to perform beyond containment functions by verifying product authenticity and safeguarding user safety and correct usage. Manufacturers are swiftly incorporating tamper-evident seals together with anti-counterfeit packaging and child-resistant features into their packaging production lines. Healthcare providers demand packaging solutions that reduce risks when medications are dispensed and administered. Accurate dosing blister packs and contamination-reducing prefilled syringes along with real-time product information smart labels are now more prevalent. The pharmaceutical packaging market growth that focuses on security and usability so drugs reach patients safely and maintain effectiveness.
E-commerce Boom Redefines Expectations in the Pharmaceutical Packaging Market: The growth of e-commerce and direct-to-patient healthcare models transforms medicine delivery and creates new requirements for pharmaceutical packaging market. The expanding use of online pharmacies for delivering prescriptions to patients' doorsteps means packaging now functions as an essential component of the healthcare experience. Modern consumers demand identical convenience and security standards for healthcare deliveries compared to their expectations from any online transaction. But pharmaceuticals come with unique challenges: Due to their temperature sensitivity and the need for tamper-proof protection pharmaceuticals must reach their destination intact and punctually. The pharmaceutical packaging market size is rapidly developing to fulfil stringent requirements of the sector. Insulated mailers and smart packaging solutions that monitor temperature in real-time have gained significant popularity because biologics, vaccines, and specialty drugs demand strict temperature control. The pharmaceutical packaging market needs to accelerate innovation at unprecedented rates to adapt to the demands of this new reality.
Stay Updated on The Latest Pharmaceutical Packaging Market Trends: https://www.theresearchinsights.com/request_sample?id=10035
Diverse Drug Delivery Formats Shaping the Future of the Pharmaceutical Packaging Market: Modern therapeutic advances have resulted in various drug delivery formats which create specialized packaging requirements and potential opportunities for pharmaceutical packaging market. The field of ophthalmic drug delivery requires sterile packaging that delivers exact doses through single-use droppers and preservative-free multi-dose systems to protect patients from microbial contamination. Advanced packaging formats like prefilled syringes, vials, and ampoules with tamper-evident seals and temperature-resistant properties maintain drug integrity during storage and transport for injectable and IV drugs used in biologics and oncology treatments. The increasing use of nasal drug delivery for local and systemic treatments, such as vaccines and emergency medications demands the creation of unit-dose or metered-dose spray packaging which supports both easy administration and patient adherence. Effective wound care packaging requires both sterile conditions and easy access which is achieved by medical-grade pouches along with barrier films and reclosable packs for clean repeated usage. The field of pulmonary drug delivery for respiratory conditions is advancing inhaler packaging and dosing systems that guarantee precise administration and enhance patient adherence through innovative designs.
Geographical Insights: The pharmaceutical packaging market is primarily dominated by North America which produces 39% of total global revenue. The region's advanced healthcare infrastructure combined with substantial investments in drug development and the establishment of major pharmaceutical companies drives its market dominance. The European region stands as the second-largest pharmaceutical packaging market with Germany, the United Kingdom, and Italy stand as major contributors to this market due to their solid regulatory systems combined with their strong emphasis on research and development. The Asia-Pacific market stands as the third-largest region in terms of market share which amounts to about 19%. The fast-paced growth of the pharmaceutical industry results from improved healthcare knowledge among populations combined with higher disposable incomes and major investments in pharmaceutical production facilities particularly located in China and India.
Pharmaceutical Packaging Market Segmentation and Geographical Insights:
Based on material, the market is divided into plastic, glass, paper & paperboard, metal and others. The plastic segment held the largest share of the pharmaceutical packaging market in 2024.
Based on packaging format, the market is divided into bottles, vials & ampoules, blister packs, syringes, bags & pouches, sachets & stick packs, cartridges, boxes & cartons and other packaging formats. The bottles segment held the largest share of the pharmaceutical packaging market in 2024.
Based on drug delivery, the market is divided into ophthalmic, injectable, iv drugs, nasal, wound care, pulmonary, oral and others (topical and transdermal treatments). The oral segment accounted for a larger share of the pharmaceutical packaging market in 2024.
Based on end-use, the market is divided into pharma manufacturing, contract packaging, retail pharmacy and institutional pharmacy. The pharma manufacturing segment accounted for a larger share of the pharmaceutical packaging market in 2024.
The pharmaceutical packaging market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa.
Purchase Premium Copy of Global Pharmaceutical Packaging Market Size and Growth Report (2025-2034) at: https://www.theresearchinsights.com/license?id=10035
Key Players and Competitive Landscape:
The Pharmaceutical Packaging Market is characterized by the presence of several major players, including:
Gerresheimer AG
Schott AG
Owens Illinois, Inc.
Amcor plc
Becton, Dickinson, and Company
AptarGroup, Inc.
West Pharmaceutical Services, Inc.
Ardagh Group S.A.
Smurfit WestRock
Comar, LLC
CCL Industries, Inc.
Vetter Pharma International
SGD Pharma
Bormioli Pharma S.p.A.
Klöckner Pentaplast
These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market.
For Region-Specific Market Data, Check Out Brief Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Pharmaceutical Packaging Market Recent Developments and Innovations:
In April 2025, Gerresheimer AG collaborated with Injecto and launched their silicone-oil- and PFAS-free syringe systems which are made from glass and cyclic olefin polymer (COP). PFAS-free syringe systems can be used for ophthalmic applications and sensitive biologics.
In January 2025, Schott AG launched next generation polymer syringe system which provides tamper evidence at individual syringe level. The integrated label concept, developed with Schreiner MediPharm, offers reliable first-opening indication, oxygen and light protection, and can include an RFID chip for accurate drug traceability and inventory management.
In October 2024, Bormioli Pharma S.p.A. partners with Chiesi Group for providing their first pharma primary packaging in carbon capture PET bottles. Carbon Capture PET bottles provide a 21.9% decrease in kg of CO2 eq compared to traditional PET.
Conclusion:
The pharmaceutical packaging market size is experiencing major changes as global healthcare trends and regulatory pressures combine with growing complexity in drug formulations. The rising popularity of e-commerce and direct-to-patient models together with biologics development requires packaging solutions that maintain safety standards while providing temperature management and supply chain traceability. The movement toward sustainable packaging solutions that support global circular economy objectives drives research into biodegradable, recyclable and refillable materials development. The variety of drug delivery methods including injectables and IV medications together with pulmonary and nasal routes leads to a need for specialized packaging solutions to match different dosage types. The pharmaceutical industry prioritizes patient safety and compliance which leads to the adoption of smart labels, prefilled devices and child-resistant technologies as standard features.
Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: https://www.theresearchinsights.com/Ask_For_Customization?id=10035
The report from The Research Insights, therefore, provides several stakeholders—including raw material suppliers, contract pharma manufacturers, and end users —with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.
With projected growth to US$ 251.6 billion by 2034, the Pharmaceutical Packaging Market represents a significant opportunity for raw material suppliers, packaging convertors, end-users, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape.
Related Report Titles:
Pharmaceutical Packaging Equipment Market Size, Share & Trends Analysis Report
Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report
Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends
Vials And Ampoules Market Size, Share & Trends Analysis Report
Small Volume Parenteral Market Size, Share & Trends Analysis Report
About Us:
The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions.
Contact Us:If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Kaushik RoyE-mail: sales@theresearchinsights.comPhone: +1 312-313-8080Website: https://www.theresearchinsights.com/
Logo: https://mma.prnewswire.com/media/2684869/The_Research_Insights_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/pharmaceutical-packaging-market-worth-251-6-billion-by-2034---exclusive-report-by-the-research-insights-302453600.html
SOURCE The Research Insights
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Nuevocor Announces FDA Clearance of IND for NVC-001 for LMNA-Related Dilated Cardiomyopathy
LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United States and Europe, who progress rapidly to end-stage heart failure. NVC-001 demonstrated significant benefits, including survival and cardiac function in preclinical models. IND clearance enables initiation of first-in-human, ascending-dose Phase 1/2 clinical trial in early 2026. SINGAPORE and PHILADELPHIA, June 10, 2025 /PRNewswire/ -- Nuevocor, a Singapore-headquartered biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for NVC-001. NVC-001 is an adeno-associated virus (AAV)-based gene therapy designed to treat LMNA-related dilated cardiomyopathy (LMNA DCM). Nuevocor plans to initiate an open-label, ascending-dose Phase 1/2 clinical trial of NVC-001 in patients with LMNA DCM. "This IND clearance marks a significant milestone in our mission to develop transformative therapies for patients with genetic cardiomyopathies by leveraging unique insights from our proprietary PrOSIA mechanobiology platform," said Dr. Yann Chong Tan, co-founder and CEO of Nuevocor. "NVC-001 is the first disease-modifying therapy for LMNA DCM designed to address the underlying mechanobiological root cause of disease. We look forward to initiating our clinical trial to bring this potentially life-changing therapy to patients." LMNA DCM is a serious genetic heart condition caused by mutations in the LMNA gene, which encodes lamin A/C – a protein essential for maintaining nuclear envelope integrity and regulating gene expression in cardiac cells. Mutations in LMNA lead to a weakening of the heart muscle, arrhythmias, and progression to end-stage heart failure. LMNA DCM is estimated to affect approximately 100,000 patients in the U.S. and Europe, representing a significant unmet medical need. NVC-001 is engineered to address the functional mechanical root cause of disease by reducing aberrant mechanical stress on the nucleus, thereby restoring nuclear envelope integrity. Nuclear envelope disruption is a hallmark of LMNA DCM. In preclinical studies, treatment with NVC-001 demonstrated significant benefits, including survival and cardiac function. The planned Phase 1/2 clinical trial is a first-in-human, 52-week open-label, multicenter, ascending-dose study designed to evaluate the safety, tolerability, and preliminary efficacy of NVC-001 in adult subjects with LMNA-DCM. NVC-001 will be administered as a one-time intravenous infusion to patients in ascending-dose cohorts. About Nuevocor Nuevocor is biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology, headquartered in Singapore with an office in the U.S. and expansion to Europe. Our unique approach, enabled by our proprietary PrOSIA mechanobiology platform, surpasses the limitations of traditional gene replacement therapy – which treats individual gene mutations – to treating defects in shared disease pathways across multiple cardiomyopathies by addressing the functional root cause of disease. Nuevocor is first-in-disease by addressing genetic cardiomyopathies that are not amendable to gene replacement therapy and have no effective treatment options. ( View original content to download multimedia: SOURCE Nuevocor Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel Advisors - Leading key players (GE Healthcare, Oracle Health, Allscripts Healthcare Solutions, Siemens Healthineers, Koninklijke Philips N.V., McKesson Corporation and Others)
NEW DELHI, June 10, 2025 /PRNewswire/ -- The Global Clinical Workflow Management Software Market size is set to experience significant growth in the coming years. Valued at around USD 11,640 Million in 2024, it is expected to soar to nearly USD 40,243 Million by 2030, with a staggering annual growth rate of about 22.97%. This growth is attributed to several key factors. The rising number of chronic illnesses and an aging population are creating a pressing need for efficient healthcare management. Additionally, government efforts to enhance digital healthcare infrastructure are playing a crucial role. With a projected shortage of 12 million healthcare professionals by 2030, especially in rural areas, the demand for workflow management systems is more critical than ever. These solutions streamline patient care and reduce delays, addressing the gap left by a lack of skilled workers. Initiatives like the HITECH Act in the U.S. and Healthy China 2030 highlight the global push towards digital healthcare, providing essential support to this burgeoning market. Furthermore, there's an increasing need for cloud-based platforms to manage healthcare data effectively, given the volume of patient records that require organization and accessibility. However, high costs associated with software installation and maintenance present challenges. Despite this, the future looks bright for clinical workflow management as technology continues to evolve, making healthcare more efficient and responsive to patient needs. Interested User Can Get a FREE PDF sample of the report here - Global Clinical Workflow Management Software Market Statistics: Market Value in 2024: USD 11,640 Million Projected Valuation by 2030: USD 40,243 Million Forecast Period CAGR: 22.97% (2025–2030) Base Year: 2024 | Historical Years: 2020–2023 Leading Segment "By Product Type": Data Integration Solutions Leading Region: North America Market Dynamic - 1.) Clinical Workflow Management Software Industry Key Driver: Rising Patient Volume & Chronic Diseases - The surge in chronic diseases like diabetes, cancer, and kidney disorders is significantly driving demand for clinical workflow management software. With China reporting approximately 139 million diabetes cases and the WHO noting 20 million new cancer cases in 2022, managing the increasing patient volume becomes challenging. This need for efficient, autonomous remote patient management solutions is a crucial factor fueling the global growth of clinical workflow management software. 2.) Clinical Workflow Management Software Market Opportunity Supportive Regulatory Frameworks - Governments worldwide are promoting remote patient care and telemedicine to enhance healthcare services. The U.S. enacted the Full Year Continuing Appropriations and Extensions Act (2025), while India introduced the Ayushman Bharat Digital Mission. China's Healthy China 2030 pilot program and Qatar's Telemedicine Regulation further signify this trend. These supportive regulatory measures foster significant growth opportunities for clinical workflow management software by expanding digital and telehealth services. 3.) Clinical Workflow Management Software Sector Challenge Limited Skilled Professionals & High Costs - Many regions, particularly rural areas, face challenges in digitalization due to financial constraints and a lack of healthcare professionals. Countries like China, India, and Brazil show low adoption rates of digital healthcare systems. Additionally, the high costs of clinical management software, varying by region, further hinder market growth. For example, software pricing ranges from USD 200 in China and India to around USD 500 in Japan, making adoption difficult for many healthcare facilities. 4.) Clinical Workflow Management Software Market Trend Rise of Cloud-Based Workflow Management Systems - The healthcare sector is increasingly adopting cloud-based workflow management systems to efficiently handle vast amounts of digital health records. Companies like Allscripts and AthenaHealth have launched platforms that enhance electronic health record management. Additionally, automated systems like eCW V12 are shaping the market positively by improving data organization and scalability. This transition to cloud solutions represents a significant trend driving future growth in the clinical workflow management software market. For in-depth analysis, market data, and forecasts, access the complete study - Global Clinical Workflow Management Software Segmentation Analysis: By Product Type (Real-Time Communication Solutions, Data Integration Solutions, Workflow Automation Solutions, Enterprise Reporting and Analytics Solutions, Care Collaboration Solutions, Others) By End User (Hospitals, Ambulatory Care Centers, Clinics & Specialty Centers, Home Healthcare Providers) By Deployment (On-Premise, Cloud-Based) - Based on Product Type: Data Integration Solutions Holds the Largest Market Share of More Than 35% Hospitals are projected to lead the Clinical Workflow Management Software market, capturing around 65% of the overall share. This dominance stems from their capacity to handle a high volume of patients daily, necessitating advanced data management solutions. The increasing demand for early disease detection and improved treatment options further drives the need for efficient workflow systems within hospital settings. Furthermore, significant government investments aimed at upgrading hospital technologies are solidifying this segment's position in the market, making hospitals key players in healthcare innovation. Industry Recent Development: 2025: GE Healthcare launched a new cloud-based portfolio called Genesis Suite, designed to help healthcare providers store, access, and manage large volumes of medical images securely from anywhere. 2024: Infor, Inc. has launched the FHIR server, a modern, scalable solution built on HL7 FHIR standards to make clinical data more accessible at the point of care. Geographically, the Global Clinical Workflow Management Software Market expands across: North America South America Europe The Middle East & Africa Asia-Pacific - North America Holds the Largest Clinical Workflow Management Software Market Share of More Than 45% North America is the clear frontrunner in the Global Clinical Workflow Management Software Market, holding over 45% of the market share. The region is experiencing a growing elderly population, which has fueled the demand for remote and virtual patient care services, particularly as seniors are prone to chronic illnesses. In fact, approximately 78% of older adults in the U.S. suffer from long-term diseases. This trend pressures healthcare providers to increase remote monitoring capabilities, as many seniors prefer receiving care at home. The dominance of North America is further reinforced by the strong development of healthcare infrastructure and the widespread adoption of IT solutions in the healthcare sector. Government investments in healthcare advancements and technology are also contributing to this region's leadership in the global market, ensuring that North America remains at the forefront of clinical workflow management innovations. Schedule a Consultation with Our Experts! – Competitive Landscape: List of Emerging Clinical Workflow Management Software Companies Globally GE Healthcare Oracle Health Allscripts Healthcare Solutions Siemens Healthineers Koninklijke Philips N.V. McKesson Corporation NextGen Healthcare Athenahealth, Inc. eClinicalWorks Cisco Systems, Inc. Epic Systems Corporation Infor, Inc. Baxter International Inc. Ascom Holding AG Others Report – List of Tables Table 1: Market Size & Analysis By Revenue (USD Million) Table 2: Market Share & Analysis By Product Type Table 3: Real-Time Communication Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 4: Data Integration Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 5: Workflow Automation Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 6: Enterprise Reporting and Analytics Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 7: Care Collaboration Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 8: Hospitals- Market Size & Forecast 2020-2030 (USD Million) Table 9: Ambulatory Care Centers- Market Size & Forecast 2020-2030 (USD Million) Table 10: On-Premise- Market Size & Forecast 2020-2030 (USD Million) Table 11: Cloud-Based- Market Size & Forecast 2020-2030 (USD Million) Table 12: North America Clinical Workflow Management Software Market Share By End User Table 13: Europe Clinical Workflow Management Software Market Size By Country Table 14: Competitive Outlook of Market Leaders Table 15: Company Profiles Overview of Key Players Report - List of Figures Figure 1: Global Clinical Workflow Management Software Market Trends & Developments Figure 2: Growth Drivers of the Global Clinical Workflow Management Software Market Figure 3: Challenges Facing the Global Clinical Workflow Management Software Market Figure 4: Regulations, Policies & Standards in Clinical Workflow Management Figure 5: Market Size & Forecast 2020-2030 by Region Figure 6: North America Market Size & Analysis By End User Figure 7: South America Market Outlook by Revenue Figure 8: Europe Market Analysis by Product Type Figure 9: Key Strategic Imperatives for Growth in Clinical Workflow Management Figure 10: Competitive Landscape of Clinical Workflow Management Software Market Looking for Regional or country-specific reports on this market? Visit our website or simply fill out the inquiry form - About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others. We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others. Similar Topic – Global Gastroesophageal Reflux Disease (GERD) Device Market Research Report: Forecast (2025-2030) - The Global Gastroesophageal Reflux Disease Device Market size was valued at around USD 2.5 billion in 2024 and is expected to reach USD 3.03 billion in 2030. Along with this, the market is estimated to grow at a CAGR of around 3.24% during the forecast period, i.e., 2025-30 Global Minimally Invasive Gastrointestinal Surgical Systems Market Research Report: Forecast (2025-2030)- The Global Minimally Invasive Gastrointestinal Surgical Systems Market size was valued at around USD 6.63 billion in 2024 and is projected to reach USD 9.64 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.43% during the forecast period, i.e., 2025-30. Global Artificial Intelligence (AI) Enabled Medical Imaging Market Research Report: Forecast (2025-2030) - The Global Artificial Intelligence (AI) Enabled Medical Imaging Market size was valued at around USD 3.23 billion in 2023 & is projected to reach around USD 16.20 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 25.9% during the forecast period, i.e., 2025-30. Global Patient Scheduling Software Market Research Report: Forecast (2025-2030) - The Global Patient Scheduling Software Market size was valued at around USD 0.41 billion in 2024 & is estimated to grow at a CAGR of around 12.82% during the forecast period, i.e., 2025-30. By 2030, the market is expected to reach USD 1.52 billion. US Clinical Documentation Improvement Market Research Report: Forecast (2025-2030) - The US Clinical Documentation Improvement Market was valued at USD 2,519.731 million in 2024 and is projected to reach USD 3,953.104 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.86% during the forecast period, 2025-30. US Ambulatory EHR Market Research Report: Forecast (2025-2030) - The US Ambulatory EHR Market size was valued at USD 3.18 billion in 2024. The market size is set to touch USD 7.84 billion in 2030 and is estimated to grow at a CAGR of around 5.3% during the forecast period, i.e., 2025-30. US Patient Referral Management Software Market Research Report: Forecast (2025-2030) - The US Patient Referral Management Software size was valued at USD 5.21 billion in 2024 and is expected to reach USD 12.34 billion in 2030. Contact:MarkNtel AdvisorsOffice No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, IndiaContact No: +91 8719999009Email: sales@ our Website: Source: Logo - View original content to download multimedia: SOURCE Markntel Advisors LLP Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel Advisors - Leading key players (GE Healthcare, Oracle Health, Allscripts Healthcare Solutions, Siemens Healthineers, Koninklijke Philips N.V., McKesson Corporation and Others)
NEW DELHI, June 10, 2025 /PRNewswire/ -- The Global Clinical Workflow Management Software Market size is set to experience significant growth in the coming years. Valued at around USD 11,640 Million in 2024, it is expected to soar to nearly USD 40,243 Million by 2030, with a staggering annual growth rate of about 22.97%. This growth is attributed to several key factors. The rising number of chronic illnesses and an aging population are creating a pressing need for efficient healthcare management. Additionally, government efforts to enhance digital healthcare infrastructure are playing a crucial role. With a projected shortage of 12 million healthcare professionals by 2030, especially in rural areas, the demand for workflow management systems is more critical than ever. These solutions streamline patient care and reduce delays, addressing the gap left by a lack of skilled workers. Initiatives like the HITECH Act in the U.S. and Healthy China 2030 highlight the global push towards digital healthcare, providing essential support to this burgeoning market. Furthermore, there's an increasing need for cloud-based platforms to manage healthcare data effectively, given the volume of patient records that require organization and accessibility. However, high costs associated with software installation and maintenance present challenges. Despite this, the future looks bright for clinical workflow management as technology continues to evolve, making healthcare more efficient and responsive to patient needs. Interested User Can Get a FREE PDF sample of the report here - Global Clinical Workflow Management Software Market Statistics: Market Value in 2024: USD 11,640 Million Projected Valuation by 2030: USD 40,243 Million Forecast Period CAGR: 22.97% (2025–2030) Base Year: 2024 | Historical Years: 2020–2023 Leading Segment "By Product Type": Data Integration Solutions Leading Region: North America Market Dynamic - 1.) Clinical Workflow Management Software Industry Key Driver: Rising Patient Volume & Chronic Diseases - The surge in chronic diseases like diabetes, cancer, and kidney disorders is significantly driving demand for clinical workflow management software. With China reporting approximately 139 million diabetes cases and the WHO noting 20 million new cancer cases in 2022, managing the increasing patient volume becomes challenging. This need for efficient, autonomous remote patient management solutions is a crucial factor fueling the global growth of clinical workflow management software. 2.) Clinical Workflow Management Software Market Opportunity Supportive Regulatory Frameworks - Governments worldwide are promoting remote patient care and telemedicine to enhance healthcare services. The U.S. enacted the Full Year Continuing Appropriations and Extensions Act (2025), while India introduced the Ayushman Bharat Digital Mission. China's Healthy China 2030 pilot program and Qatar's Telemedicine Regulation further signify this trend. These supportive regulatory measures foster significant growth opportunities for clinical workflow management software by expanding digital and telehealth services. 3.) Clinical Workflow Management Software Sector Challenge Limited Skilled Professionals & High Costs - Many regions, particularly rural areas, face challenges in digitalization due to financial constraints and a lack of healthcare professionals. Countries like China, India, and Brazil show low adoption rates of digital healthcare systems. Additionally, the high costs of clinical management software, varying by region, further hinder market growth. For example, software pricing ranges from USD 200 in China and India to around USD 500 in Japan, making adoption difficult for many healthcare facilities. 4.) Clinical Workflow Management Software Market Trend Rise of Cloud-Based Workflow Management Systems - The healthcare sector is increasingly adopting cloud-based workflow management systems to efficiently handle vast amounts of digital health records. Companies like Allscripts and AthenaHealth have launched platforms that enhance electronic health record management. Additionally, automated systems like eCW V12 are shaping the market positively by improving data organization and scalability. This transition to cloud solutions represents a significant trend driving future growth in the clinical workflow management software market. For in-depth analysis, market data, and forecasts, access the complete study - Global Clinical Workflow Management Software Segmentation Analysis: By Product Type (Real-Time Communication Solutions, Data Integration Solutions, Workflow Automation Solutions, Enterprise Reporting and Analytics Solutions, Care Collaboration Solutions, Others) By End User (Hospitals, Ambulatory Care Centers, Clinics & Specialty Centers, Home Healthcare Providers) By Deployment (On-Premise, Cloud-Based) - Based on Product Type: Data Integration Solutions Holds the Largest Market Share of More Than 35% Hospitals are projected to lead the Clinical Workflow Management Software market, capturing around 65% of the overall share. This dominance stems from their capacity to handle a high volume of patients daily, necessitating advanced data management solutions. The increasing demand for early disease detection and improved treatment options further drives the need for efficient workflow systems within hospital settings. Furthermore, significant government investments aimed at upgrading hospital technologies are solidifying this segment's position in the market, making hospitals key players in healthcare innovation. Industry Recent Development: 2025: GE Healthcare launched a new cloud-based portfolio called Genesis Suite, designed to help healthcare providers store, access, and manage large volumes of medical images securely from anywhere. 2024: Infor, Inc. has launched the FHIR server, a modern, scalable solution built on HL7 FHIR standards to make clinical data more accessible at the point of care. Geographically, the Global Clinical Workflow Management Software Market expands across: North America South America Europe The Middle East & Africa Asia-Pacific - North America Holds the Largest Clinical Workflow Management Software Market Share of More Than 45% North America is the clear frontrunner in the Global Clinical Workflow Management Software Market, holding over 45% of the market share. The region is experiencing a growing elderly population, which has fueled the demand for remote and virtual patient care services, particularly as seniors are prone to chronic illnesses. In fact, approximately 78% of older adults in the U.S. suffer from long-term diseases. This trend pressures healthcare providers to increase remote monitoring capabilities, as many seniors prefer receiving care at home. The dominance of North America is further reinforced by the strong development of healthcare infrastructure and the widespread adoption of IT solutions in the healthcare sector. Government investments in healthcare advancements and technology are also contributing to this region's leadership in the global market, ensuring that North America remains at the forefront of clinical workflow management innovations. Schedule a Consultation with Our Experts! – Competitive Landscape: List of Emerging Clinical Workflow Management Software Companies Globally GE Healthcare Oracle Health Allscripts Healthcare Solutions Siemens Healthineers Koninklijke Philips N.V. McKesson Corporation NextGen Healthcare Athenahealth, Inc. eClinicalWorks Cisco Systems, Inc. Epic Systems Corporation Infor, Inc. Baxter International Inc. Ascom Holding AG Others Report – List of Tables Table 1: Market Size & Analysis By Revenue (USD Million) Table 2: Market Share & Analysis By Product Type Table 3: Real-Time Communication Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 4: Data Integration Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 5: Workflow Automation Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 6: Enterprise Reporting and Analytics Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 7: Care Collaboration Solutions- Market Size & Forecast 2020-2030 (USD Million) Table 8: Hospitals- Market Size & Forecast 2020-2030 (USD Million) Table 9: Ambulatory Care Centers- Market Size & Forecast 2020-2030 (USD Million) Table 10: On-Premise- Market Size & Forecast 2020-2030 (USD Million) Table 11: Cloud-Based- Market Size & Forecast 2020-2030 (USD Million) Table 12: North America Clinical Workflow Management Software Market Share By End User Table 13: Europe Clinical Workflow Management Software Market Size By Country Table 14: Competitive Outlook of Market Leaders Table 15: Company Profiles Overview of Key Players Report - List of Figures Figure 1: Global Clinical Workflow Management Software Market Trends & Developments Figure 2: Growth Drivers of the Global Clinical Workflow Management Software Market Figure 3: Challenges Facing the Global Clinical Workflow Management Software Market Figure 4: Regulations, Policies & Standards in Clinical Workflow Management Figure 5: Market Size & Forecast 2020-2030 by Region Figure 6: North America Market Size & Analysis By End User Figure 7: South America Market Outlook by Revenue Figure 8: Europe Market Analysis by Product Type Figure 9: Key Strategic Imperatives for Growth in Clinical Workflow Management Figure 10: Competitive Landscape of Clinical Workflow Management Software Market Looking for Regional or country-specific reports on this market? Visit our website or simply fill out the inquiry form - About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others. We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others. Similar Topic – Global Gastroesophageal Reflux Disease (GERD) Device Market Research Report: Forecast (2025-2030) - The Global Gastroesophageal Reflux Disease Device Market size was valued at around USD 2.5 billion in 2024 and is expected to reach USD 3.03 billion in 2030. Along with this, the market is estimated to grow at a CAGR of around 3.24% during the forecast period, i.e., 2025-30 Global Minimally Invasive Gastrointestinal Surgical Systems Market Research Report: Forecast (2025-2030)- The Global Minimally Invasive Gastrointestinal Surgical Systems Market size was valued at around USD 6.63 billion in 2024 and is projected to reach USD 9.64 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 6.43% during the forecast period, i.e., 2025-30. Global Artificial Intelligence (AI) Enabled Medical Imaging Market Research Report: Forecast (2025-2030) - The Global Artificial Intelligence (AI) Enabled Medical Imaging Market size was valued at around USD 3.23 billion in 2023 & is projected to reach around USD 16.20 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 25.9% during the forecast period, i.e., 2025-30. Global Patient Scheduling Software Market Research Report: Forecast (2025-2030) - The Global Patient Scheduling Software Market size was valued at around USD 0.41 billion in 2024 & is estimated to grow at a CAGR of around 12.82% during the forecast period, i.e., 2025-30. By 2030, the market is expected to reach USD 1.52 billion. US Clinical Documentation Improvement Market Research Report: Forecast (2025-2030) - The US Clinical Documentation Improvement Market was valued at USD 2,519.731 million in 2024 and is projected to reach USD 3,953.104 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.86% during the forecast period, 2025-30. US Ambulatory EHR Market Research Report: Forecast (2025-2030) - The US Ambulatory EHR Market size was valued at USD 3.18 billion in 2024. The market size is set to touch USD 7.84 billion in 2030 and is estimated to grow at a CAGR of around 5.3% during the forecast period, i.e., 2025-30. US Patient Referral Management Software Market Research Report: Forecast (2025-2030) - The US Patient Referral Management Software size was valued at USD 5.21 billion in 2024 and is expected to reach USD 12.34 billion in 2030. Contact:MarkNtel AdvisorsOffice No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, IndiaContact No: +91 8719999009Email: sales@ our Website: Source: Logo - View original content to download multimedia: SOURCE Markntel Advisors LLP Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data